The hyperhidrosis treatment market, had a valuation of USD 1.43 Billion in 2021 and is projected to experience a compound annual growth rate (CAGR) of 5.8% during the forecast period. Factors such as increased awareness among individuals, advancements in technology, and notable progress in electronic and laser therapies are anticipated to contribute to the growth of market revenue. Furthermore, the availability of health coverage from both private and public companies has led to a higher demand for hyperhidrosis treatments globally, as more individuals are likely to seek diagnosis and treatment. Primary axillary hyperhidrosis is a condition characterized by excessive perspiration in the underarm region, causing disruptions in daily activities and lacking a known cause. In Japan, it is estimated that 5.75% of the population, or approximately 1 in 20 people, suffer from primary axillary hyperhidrosis.
https://www.reportsanddata.com..../report-detail/hyper